1
|
Hewitt J, Azhari HF, O’Neill M, Smith A, Quinn T, Dawson J. Post-stroke diabetes management: a qualitative study. Front Neurol 2024; 15:1364217. [PMID: 38682037 PMCID: PMC11055455 DOI: 10.3389/fneur.2024.1364217] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2024] [Accepted: 04/03/2024] [Indexed: 05/01/2024] Open
Abstract
Introduction Diabetes is associated with an increased risk of stroke. In many cases, a diabetes diagnosis may predate a stroke; however, diabetes is often diagnosed during the hospital admission following a stroke. To explore the experiences of stroke survivors as they cope with a new diabetes diagnosis, particularly regarding developing an effective strategy for managing the disease. Methods A qualitative grounded theory approach was used that employed focus group interviews with participants, including clinicians and stroke survivors, to develop a holistic understanding of primary and secondary stroke care services and the experiences of those accessing them. Results Clinicians believed they were not optimally equipped to manage diabetes as a condition. They believed more emphasis should be placed on self-management, which would be better managed by lifestyle changes than medication alone. Conversely, stroke survivors with diabetes experienced an additional burden associated with the diagnoses but relied on clinicians to manage their diabetes and believed the clinicians were failing if they were unwilling or unable to achieve this. Discussion The research highlights the tensions between stroke survivors and healthcare professionals. Stroke survivors relied on the healthcare teams to provide the optimal treatment when they had recently undergone a significant health event where they had experienced a stroke and received a diabetes diagnosis. However, the healthcare teams, while recognizing the importance of a holistic and comprehensive treatment package, struggled to provide it due to resource limitations. To optimize post-stroke diabetes self-management education, a strategic framework that prioritizes patient empowerment and interdisciplinary collaboration is paramount. Tailoring educational interventions to align with individual patient profiles-considering their unique health status, personal preferences, and cultural context-is essential for fostering self-efficacy. Such a strategy not only empowers patients to take an active role in managing their diabetes post-stroke but also contributes to superior health outcomes and an elevated standard of living.
Collapse
Affiliation(s)
- Jonathan Hewitt
- School of Geriatric Medicine, Cardiff University, Cardiff, United Kingdom
| | - Hala F. Azhari
- College of Medicine and Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia
| | - Martin O’Neill
- Social and Economic Research Data and Methods, Cardiff University, Cardiff, United Kingdom
| | - Alexander Smith
- Clinical Research and Innovation Centre, St Woolos Hopsital, Newport, United Kingdom
| | - Terence Quinn
- School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom
| | - Jesse Dawson
- School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom
| |
Collapse
|
2
|
Azhari H, Hewitt J, Smith A, O’Neill M, Quinn T, Dawson J. Pioglitazone and barriers to effective post-stroke comorbidity management in stroke survivors with diabetes. Neurosciences (Riyadh) 2024; 29:44-50. [PMID: 38195138 PMCID: PMC10827012 DOI: 10.17712/nsj.2024.1.20230043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 05/31/2023] [Accepted: 11/20/2023] [Indexed: 01/11/2024]
Abstract
OBJECTIVES To explore the barriers preventing pioglitazone use in stroke survivors and primary and secondary stroke care services. METHODS A qualitative grounded theory approached design was used to assess post-stroke diabetes treatments and to assess clinical applicability of pioglitazone as a preventive treatment to minimize its side effects (SEs) associated. Three focus groups were established with 48 participants from Scotland and Wales health board centers during January 2019 to July 2022. RESULTS A qualitative grounded theory approached design was used to assess post-stroke diabetes treatments and to assess clinical applicability of pioglitazone as a preventive treatment to minimize its SEs associated. Three focus groups were established with 48 participants from Scotland and Wales health board centers during January 2019 to July 2022. CONCLUSION These strategies might allow greater treatment adherence by stroke survivors and increased confidence of the health care professionals in their practice. The findings suggest that further research will be needed to facilitate wider usage of pioglitazone in treating people with stroke and health education is necessitate when using diabetes drugs post-stroke.
Collapse
Affiliation(s)
- Hala Azhari
- From the College of Medicine and Pharmacy (Azhari), Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia, from the School of Cardiovascular and Metabolic Health (Azhari, Quinn, Dawson), University of Glasgow, Glasgow, from the School of Geriatric Medicine Centre (Hewitt, O’Neill), Cardiff University, and from the Clinical Research and Innovation Centre (Smith), Aneurin Bevan University Health Board, Newport, United Kingdom
| | - Jonathan Hewitt
- From the College of Medicine and Pharmacy (Azhari), Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia, from the School of Cardiovascular and Metabolic Health (Azhari, Quinn, Dawson), University of Glasgow, Glasgow, from the School of Geriatric Medicine Centre (Hewitt, O’Neill), Cardiff University, and from the Clinical Research and Innovation Centre (Smith), Aneurin Bevan University Health Board, Newport, United Kingdom
| | - Alexander Smith
- From the College of Medicine and Pharmacy (Azhari), Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia, from the School of Cardiovascular and Metabolic Health (Azhari, Quinn, Dawson), University of Glasgow, Glasgow, from the School of Geriatric Medicine Centre (Hewitt, O’Neill), Cardiff University, and from the Clinical Research and Innovation Centre (Smith), Aneurin Bevan University Health Board, Newport, United Kingdom
| | - Martin O’Neill
- From the College of Medicine and Pharmacy (Azhari), Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia, from the School of Cardiovascular and Metabolic Health (Azhari, Quinn, Dawson), University of Glasgow, Glasgow, from the School of Geriatric Medicine Centre (Hewitt, O’Neill), Cardiff University, and from the Clinical Research and Innovation Centre (Smith), Aneurin Bevan University Health Board, Newport, United Kingdom
| | - Terence Quinn
- From the College of Medicine and Pharmacy (Azhari), Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia, from the School of Cardiovascular and Metabolic Health (Azhari, Quinn, Dawson), University of Glasgow, Glasgow, from the School of Geriatric Medicine Centre (Hewitt, O’Neill), Cardiff University, and from the Clinical Research and Innovation Centre (Smith), Aneurin Bevan University Health Board, Newport, United Kingdom
| | - Jesse Dawson
- From the College of Medicine and Pharmacy (Azhari), Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia, from the School of Cardiovascular and Metabolic Health (Azhari, Quinn, Dawson), University of Glasgow, Glasgow, from the School of Geriatric Medicine Centre (Hewitt, O’Neill), Cardiff University, and from the Clinical Research and Innovation Centre (Smith), Aneurin Bevan University Health Board, Newport, United Kingdom
| |
Collapse
|
3
|
Gately K, Heavey S, Cuffe S, Finn S, O’Byrne K, O’Neill M, Moore G. PO-505 Targeting PIM kinase to overcome resistance to PI3K-mTOR inhibition in NSCLC. ESMO Open 2018. [DOI: 10.1136/esmoopen-2018-eacr25.520] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
4
|
Moore G, Heavey S, O’Byrne K, Cuffe S, Finn S, O’Neill M, Gately K. Activated cMyc/PIM kinase promotes resistance to PI3K/mTOR inhibition in NSCLC. Lung Cancer 2018. [DOI: 10.1016/s0169-5002(18)30030-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
5
|
McNeill S, Kumar D, O’Neill M, King C, McBride F, Butler C. Improving ward round standards with the use of a structured pro-forma. Future Hosp J 2017. [DOI: 10.7861/futurehosp.4-2-s21] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
6
|
Abstract
Effective response planning and preparedness are critical to the health and well-being of communities in the face of biological emergencies. Response plans involving mass prophylaxis may seem feasible when considering the choice of dispensing points within a region, overall population density, and estimated traffic demands. However, the plan may fail to serve particular vulnerable subpopulations, resulting in access disparities during emergency response. For a response plan to be effective, sufficient mitigation resources must be made accessible to target populations within short, federally-mandated time frames. A major challenge in response plan design is to establish a balance between the allocation of available resources and the provision of equal access to PODs for all individuals in a given geographic region. Limitations on the availability, granularity, and currency of data to identify vulnerable populations further complicate the planning process. To address these challenges and limitations, data driven methods to quantify vulnerabilities in the context of response plans have been developed and are explored in this article.
Collapse
Affiliation(s)
- Saratchandra Indrakanti
- Center for Computational Epidemiology and Response Analysis (CeCERA), University of North Texas, Denton, Texas, United States of America
- * E-mail:
| | - Armin R. Mikler
- Center for Computational Epidemiology and Response Analysis (CeCERA), University of North Texas, Denton, Texas, United States of America
| | - Martin O’Neill
- Center for Computational Epidemiology and Response Analysis (CeCERA), University of North Texas, Denton, Texas, United States of America
| | - Chetan Tiwari
- Center for Computational Epidemiology and Response Analysis (CeCERA), University of North Texas, Denton, Texas, United States of America
| |
Collapse
|
7
|
Bousquet J, Kuh D, Bewick M, Strandberg T, Farrell J, Pengelly R, Joel M, Rodriguez Mañas L, Mercier J, Bringer J, Camuzat T, Bourret R, Bedbrook A, Kowalski M, Samolinski B, Bonini S, Brayne C, Michel J, Venne J, Viriot-Durandal P, Alonso J, Avignon A, Bousquet P, Combe B, Cooper R, Hardy R, Iaccarino G, Keil T, Kesse-Guyot E, Momas I, Ritchie K, Robine J, Thijs C, Tischer C, Vellas B, Zaidi A, Alonso F, Andersen Ranberg K, Andreeva V, Ankri J, Arnavielhe S, Arshad S, Augé P, Berr C, Bertone P, Blain H, Blasimme A, Buijs G, Caimmi D, Carriazo A, Cesario A, Coletta J, Cosco T, Criton M, Cuisinier F, Demoly P, Fernandez-Nocelo S, Fougère B, Garcia-Aymerich J, Goldberg M, Guldemond N, Gutter Z, Harman D, Hendry A, Heve D, Illario M, Jeandel C, Krauss-Etschmann S, Krys O, Kula D, Laune D, Lehmann S, Maier D, Malva J, Matignon P, Melen E, Mercier G, Moda G, Nizinkska A, Nogues M, O’Neill M, Pelissier J, Poethig D, Porta D, Postma D, Puisieux F, Richards M, Robalo-Cordeiro C, Romano V, Roubille F, Schulz H, Scott A, Senesse P, Slagter S, Smit H, Somekh D, Stafford M, Suanzes J, Todo-Bom A, Touchon J, Traver-Salcedo V, Van Beurden M, Varraso R, Vergara I, Villalba-Mora E, Wilson N, Wouters E, Zins M. Operative definition of active and healthy ageing (AHA): Meeting report. Montpellier October 20–21, 2014. Eur Geriatr Med 2015. [DOI: 10.1016/j.eurger.2014.12.006] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
8
|
Panayiotou M, King AP, Ma Y, Housden RJ, Rinaldi CA, Gill J, Cooklin M, O’Neill M, Rhode KS. A statistical model of catheter motion from interventional x-ray images: application to image-based gating. Phys Med Biol 2013; 58:7543-62. [DOI: 10.1088/0031-9155/58/21/7543] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
|
9
|
Balogh E, Dias JM, Mullan R, Harty LC, Gallagher P, Molloy M, O’Flynn E, O’Kelly A, O’Neill M, Moore L, Murray M, FitzGerald O, Fearon U, Veale DJ. THU0149 Comparison of ACR/EULAR and DAS28 Remission Criteria in a Cohort of TNF Inhibitor Treated Rheumatoid Arthritis Patients. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.677] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
10
|
O’Neill M. High performance school-age athletes: A study of conflicting demands. J Sci Med Sport 2012. [DOI: 10.1016/j.jsams.2012.11.376] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
11
|
Dekker GA, Chan A, Luke CG, Priest K, Riley M, Halliday J, King JF, Gee V, O’Neill M, Snell M, Cull V, Cornes S. Risk of uterine rupture in Australian women attempting vaginal birth after one prior caesarean section: a retrospective population-based cohort study. BJOG 2010; 117:1358-65. [DOI: 10.1111/j.1471-0528.2010.02688.x] [Citation(s) in RCA: 70] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
12
|
McMillan N, Dunne G, Smith S, O’Rourke B, Morrin D, McDonnell L, O’Neill M, Riedel S, Krägel J, Mitchell C, Scully P. New tensiographic approach to surface studies of protein kinetics showing possible structural rearrangement of protein layers on polymer substrates. Colloids Surf A Physicochem Eng Asp 2010. [DOI: 10.1016/j.colsurfa.2010.05.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
13
|
Dunne G, McMillan N, O’Rourke B, Morrin D, O’Neill M, Reidel S, McDonell L, Scully P. Experimental tensiometric protein adsorption studies. Colloids Surf A Physicochem Eng Asp 2010. [DOI: 10.1016/j.colsurfa.2009.06.030] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
14
|
Uronis HE, Bullock K, Blobe G, Hsu S, Morse M, Nixon A, Haley S, O’Neill M, Hurwitz H, Bendell J. A phase I study of gemcitabine plus dasatinib (GD) or gemcitabine plus dasatinib plus cetuximab (GDC) in refractory solid tumors. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e15506] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e15506 Background: Dasatinib (D) is a small molecule tyrosine kinase inhibitor with activity against both bcr-abl and src. Cetuximab (C) is a monoclonal antibody that blocks EGFR. Preclinical models suggest D reverses resistance to G. In addition, src and EGFR pathways interact; synergism of dual blockade by D + C is possible. We evaluated two combination regimens, GD and GDC, in a Phase I dose escalation study. Methods: Patients (pts) with advanced solid tumors were enrolled in cohorts of 3–6 to either GD or GDC. G was dosed in mg/m2 weekly for 3 of 4 weeks, D was dosed in mg PO BID, and C was dosed at 250 mg/m2 weekly after loading dose of C=400; cycle length was 28 days. Dose levels were as follows: 1) G 1000 + D 50 ± C; 2) G 1,000 + D 70 ± C; 3) G 1,000 + D 100 ± C. Standard cycle 1 DLT definitions were used. Eligible pts had advanced solid tumors, adequate organ and marrow function, and no co-morbidities that would increase risk of toxicity. Serum, plasma, and skin biopsy biomarkers were obtained pre- and on treatment. Results: 25 pts have been enrolled, including 21 with pancreatic adenocarcinoma, 3 of whom had received prior G. 21 pts were evaluable for toxicity and 18 for efficacy. Four DLT were observed: Gr 3 ANC with infection (GDC1, n=1), Gr 3 ALT (GD2, n=2), and Gr 5 pneumonitis (GDC2, n=1). Possible treatment-related adverse events in later cycles included: Gr3–4 ANC (n=4), Gr4 colitis (n=1), Gr3 bilirubin (n=2), Gr3 Hgb (n=2), Gr3 Plt (n=2), Gr3 edema/fluid retention syndrome (n=1), and Gr3 vomiting (n=2). One previously untreated pt had a partial response. Eight of 18 pts, 3 of whom had received prior G, had stable disease as best response, median duration = 5 months (range 1–7). Biomarker results are pending. Conclusions: The MTD of the GD arm is G1000/D50BID. Stable disease in previous G-refractory pts was noted. Hematologic toxicities were dose-limiting; later toxicities including hematologic, LFT changes, pneumonitis, and fluid retention were seen. To address these toxicities, once daily dosing of D will be explored, followed by an expanded cohort of G + daily D vs G + bid D in pts with treatment-naïve pancreatic cancer. [Table: see text]
Collapse
Affiliation(s)
- H. E. Uronis
- Duke University, Durham, NC; Sarah Cannon Research Institute, Nashville, TN
| | - K. Bullock
- Duke University, Durham, NC; Sarah Cannon Research Institute, Nashville, TN
| | - G. Blobe
- Duke University, Durham, NC; Sarah Cannon Research Institute, Nashville, TN
| | - S. Hsu
- Duke University, Durham, NC; Sarah Cannon Research Institute, Nashville, TN
| | - M. Morse
- Duke University, Durham, NC; Sarah Cannon Research Institute, Nashville, TN
| | - A. Nixon
- Duke University, Durham, NC; Sarah Cannon Research Institute, Nashville, TN
| | - S. Haley
- Duke University, Durham, NC; Sarah Cannon Research Institute, Nashville, TN
| | - M. O’Neill
- Duke University, Durham, NC; Sarah Cannon Research Institute, Nashville, TN
| | - H. Hurwitz
- Duke University, Durham, NC; Sarah Cannon Research Institute, Nashville, TN
| | - J. Bendell
- Duke University, Durham, NC; Sarah Cannon Research Institute, Nashville, TN
| |
Collapse
|
15
|
O’Neill M, Brown VJ. The effect of striatal dopamine depletion and the adenosine A2A antagonist KW-6002 on reversal learning in rats. Neurobiol Learn Mem 2007; 88:75-81. [DOI: 10.1016/j.nlm.2007.03.003] [Citation(s) in RCA: 77] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2006] [Revised: 02/08/2007] [Accepted: 03/06/2007] [Indexed: 11/16/2022]
|
16
|
Bendell JC, George D, Nixon A, Yu D, Petros W, Beci R, Arrowood C, Lockamy D, O’Neill M, Hurwitz H. Results of a phase I study of bevacizumab (BV), everolimus (EV), and erlotinib (E) in patients with advanced solid tumors. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.3548] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
3548 Background: BV inhibits vascular endothelial growth factor (VEGF). EV is an mTOR (mammalian target of rapamycin) inhibitor. E inhibits epidermal growth factor receptor (EGFR) tyrosine kinase. VEGF, mTOR, and EGFR inhibitors have anti-tumor and anti-angiogenesis effects alone and in combination in preclinical models. As a combination targeted therapy, we evaluated BV + EV + E in a phase I, pharmacokinetic (PK), biomarker study. Methods: Cycle length was 28 days. Doses: BV 10mg/kg IV q14d. EV 5mg PO QD, escalating to 10mg QD. Once the recommended phase II dose (RPTD) of BV + EV was reached, E was added, starting at 75 mg PO QD. DLT was defined as any treatment-related grade 4 heme or grade 3/4 non-heme event in Cycle 1. Results: 34 pts have been enrolled (18 F, 16 M), 28 evaluable for DLT, 24 for efficacy. Median age is 58y (range 29–73). Dose level 1 (BV 10mg/EV 5mg) had no DLT’s. Dose level 2 (BV 10mg/EV 10mg) had no DLT’s and the cohort was expanded to 13 evaluable pts. E (75mg) was added to BV 10mg/ EV 10mg. 2/6 patients had DLT (grade 3 mucositis and grade 3 rash). The doses were adjusted to BV 5mg/EV 5mg/E 75mg. 3 patients had no DLT and this dose is the MTD and RPTD for the 3-drug combination. 20 more patients are being enrolled at the RPTD for biomarker studies. Other grade ¾ toxicity included: nephrotic syndrome, cardiac ischemia, ventricular thrombus, portacath thrombosis, and bowel perforation. 2 patients had PR: 1 renal and 1 osteosarcoma. 16/24 pts had SD (10–112+ weeks). 5/6 patients with colorectal cancer (CRC) previously progressing on BV had SD (16+ - 112 weeks). One CRC patient had 19% radiologic decrease. Conclusions: BV + EV + E preliminary clinical activity (notably in refractory CRC) and class-related side effects were seen. The MTD is BV 5mg/kg IV q14d + EV 5mg PO QD + E 75mg PO QD. Updated data will be presented. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- J. C. Bendell
- Duke University Medical Center, Durham, NC; West Virginia University, Morgantown, WV
| | - D. George
- Duke University Medical Center, Durham, NC; West Virginia University, Morgantown, WV
| | - A. Nixon
- Duke University Medical Center, Durham, NC; West Virginia University, Morgantown, WV
| | - D. Yu
- Duke University Medical Center, Durham, NC; West Virginia University, Morgantown, WV
| | - W. Petros
- Duke University Medical Center, Durham, NC; West Virginia University, Morgantown, WV
| | - R. Beci
- Duke University Medical Center, Durham, NC; West Virginia University, Morgantown, WV
| | - C. Arrowood
- Duke University Medical Center, Durham, NC; West Virginia University, Morgantown, WV
| | - D. Lockamy
- Duke University Medical Center, Durham, NC; West Virginia University, Morgantown, WV
| | - M. O’Neill
- Duke University Medical Center, Durham, NC; West Virginia University, Morgantown, WV
| | - H. Hurwitz
- Duke University Medical Center, Durham, NC; West Virginia University, Morgantown, WV
| |
Collapse
|
17
|
MacLeod N, O’Neill M, Walsh S. A Comparison between Morphometric and Artificial Neural Network Approaches to the Automated Species Recognition Problem in Systematics. Systematics Association Special Volumes 2007. [DOI: 10.1201/9781439832547.ch5] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
18
|
McMillan N, O’Rourke B, Riedel S, O’Neill M, O’Neill A, Bertho A, Doyle G, Beverley K, Hammond J, Augousti A, Mason J, Skelly D, O’Neill A, Boller D, Cave S. A new democratic phase coherent data-scatter technique for calibration, measurement, fingerprinting and rapid archival identification of ultraviolet-visible multi-component food spectra. Anal Chim Acta 2004. [DOI: 10.1016/j.aca.2003.10.084] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
19
|
|
20
|
O’Neill M, Wright C, Fitz F. Quality evaluation in on‐line service environments: an application of the importance‐performance measurement technique. ACTA ACUST UNITED AC 2001. [DOI: 10.1108/eum0000000006519] [Citation(s) in RCA: 55] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
21
|
|
22
|
O’Neill M, Charters S. Service quality at the cellar door: implications for Western Australia’s developing wine tourism industry. ACTA ACUST UNITED AC 2000. [DOI: 10.1108/09604520010318308] [Citation(s) in RCA: 101] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
23
|
O’Neill M, Getz D, Carlsen J. Evaluation of service quality at events: the 1998 Coca‐Cola Masters Surfing event at Margaret River, Western Australia. ACTA ACUST UNITED AC 1999. [DOI: 10.1108/09604529910267064] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
24
|
Lee TC, Shine JD, FitzPatrick DP, Bradley JA, O’Connor JJ, O’Kelly KU, Carr AJ, McCormack BAO, O’Neill P, Cole JS, Watterson JK, Raghunathan S, O’Reilly MJG, Pherwani A, Rice J, McCormack D, Maher SA, Prendergast PJ, Reid AJ, Waide DV, Chambers SD, Bartlett RH, Ceccio SL, Murphy LA, Lacroix D, Murphy BP, Mullett H, Shannon F, Lawlor G, O’Rourke SK, Connolly P, Maher S, Devitt A, McElwain J, O’Reilly P, McCarthy DR, Kernohan G, Buchanan FJ, Sim B, Downes S, Bennett DB, Orr JF, Dorrell PF, Fleming P, Stephens M, Moholkar K, Fenelon G, Doyle AM, Dockrell S, Normoyle P, Geraghty D, MacNamara S, Lacey G, Lally C, McGloughlin T, Grace P, Walsh M, McGIoughlin T, Colgan D, Daly S, Dolan B, Flynn MJ, Shuhaibar M, Neligan MC, McMillan ND, O’Mongain E, Walsh J, Miller R, Mitchell I, O’Neill M, Brennan F, Ridgway P, Blayney AW, Monkhouse WS, O’Brien FJ, Taylor D, Mushipe MT, Shelton JC, Revell PA, McCarthy MA, Pearse KM, O’Keefe DT, Lyons GM, Leane GE, Mulcahy E, Bray K, Conway BA, Halliday DM, Rosenberg JR, Anderson R, Grace PA, Kinsella SM, Harrison AJ, Lyons DJ, Wallace KE, Hill RG, Pembroke JT, Brown CJ, Hatton PV, Bryan K, Buggy M, Noe JM, Nico AC, McConnell LA, McGivern RC, Marsh DR, Meenan BJ, Workman A, Kuiper JH. Royal Academy of Medicine in Ireland Section of Bioengineering. Ir J Med Sci 1999. [DOI: 10.1007/bf02945855] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
25
|
Cullinane A, Coca-Prados M, Harvey B, O’Reilly C, Ryan MP, Maguire D, O’Sullivan G, Harvey BJ, Gebruers EM, Hall WJ, Harris AM, O’Halloran KD, Curran AK, Bradford A, Bunting HE, McConaghy P, McLoughlin C, Sweeney D, Hardiman O, Grealy M, Sreenan JM, Gilmartin L, O’Cuinn G, Lawlor M, O’Boyle KM, Farrell CB, Foster NEL, Walsh DM, Baxter GD, Allen JM, Cawley T, Breslin E, Docherty JR, Hynes AC, Kane MT, Duffy C, Mohd Nor A, Johnson AH, Tomkin GH, Collins PB, Crónín DÓ, McCloskey S, Thornbury KD, O’Rourke M, Kearns S, Campion DP, Leek BF, Curran AK, Curran AK, O’Regan RG, McLaughlin N, Curran AK, Gaffney J, Edgell TA, Walker JM, MacSweeney CP, Faherty C, Kelly JP, Leonard BE, Earley B, O’Neill M, Reymann JM, Allain H, Caldwell M, Jennings M, Prosser E, Urbach V, Horwitz E, Horwitz ER, Presser E, Raffin JP, Thomas S, Egan DA, O’Farrell A. Royal academy of medicine in Ireland section of biomedical sciences Proceedings of Summer Meeting held June, 1994. Ir J Med Sci 1995. [DOI: 10.1007/bf02968123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
26
|
|
27
|
Doolan CM, Keenan AK, Costello CM, McQuaid K, O’Connor CM, Fitzgerald MX, Southey A, Ryan P, Kelly J, Leonard BE, Grace D, Fee JPH, Milligan KR, Brazil D, Clyne C, Camps M, McHale NG, Keenan AK, Gierschik P, Caldwell M, O’Neill M, Earley B, Thornton F, Martin F, O’Connnell A, Benicourt C, O’Donnell JM, Banyasz T, Kovacs T, Campion DP, Leek BF, Smith KM, Docherty JR, McNamara M, Kelly JP, McGarvey C, O’Donnell J, Nsimba SED, Kelly BE, MacSweeney C, Redrobe JP, Browne I, Gavin K, Thomas G, Docherty JR, Ryan M, Burke W, McDonnell T, Clyne CD, Healy E, Hunt A, Ryan MP, Tashani OA, Curran AK, O’Halloran KD, Bradford A, O’Halloran KD, Ryan JP, Rousseau JP, Kearns PO, Quinn TM, Kevin LG, Doran M, Tansey D, Boylan J, McShane AJ, Wen Y, Feely J, Lowe AS, Baxter GD, Walsh DM, McDowell B, Allen JM, McDowell BC, Allen IM, Niveditha Y, O’Donovan DJ, O’Neill J, Powell D, Kernan RP, Foster NEL, Orr A. Royal academy of medicine in Ireland section of biomedical sciences. Ir J Med Sci 1994. [DOI: 10.1007/bf02943263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
28
|
Chan KH, Singh HP, Aherne T, Carabine U, Gilliland H, Johnston JR, Lowry KG, McGuigan J, Cosgrove J, Veerasingham D, McCarthy J, Hurley J, Wood AE, Gilliland R, McGuigan JA, McManus KG, Wilkinson P, Johnston LC, MacMahon J, Wilson D, Austin C, Anikin V, McManus K, McGuigan J, McManus K, Anikin V, Gibbons JRP, McGuigan J, Sharkey R, Long M, Maree A, O’Neill S, Maguire CP, Hayes JP, Masterson J, Fitzgerald MX, Hayes M, Maguire CP, Hayes JP, Masterson J, Fitzgerald MX, Quigley C, Mofidi A, Mofidi R, Fitzgerald MX, O’Neill M, Watson JBG, O’Halloran ET, Shortt C, Taylor M, Holland C, O’Lorcain P, Taylor M, Holland C, O’Lorcain P, Pathmakanthan S, Sreenan S, Power CK, Poulter LW, Burke CM, Reilly D, Pathmakanthan S, Sreenan S, Doyle S, Burke CM, Sreenan S, Power C, Pathmakanthan S, Goggin A, Burke CM, Poulter LW, Sreenan S, Doyle S, Pathmakanthan S, Poulter LW, Burke CM, Sreenan S, Debenham P, Pathmakanthan S, Burke CM, Poulter LW, Southey A, O’Connor CM, Fitzgerald MX, Bourke WJ, McDonnell TJ, Buck JB, Magee TRA, Lowry RC, Graham ANJ, Owens WA, Kelly SB, McGuigan JA, Costelloe RW, Ryan J, Collins J, Guerin D, Rooney D, Long E, O’Donnell M, O’Neill S, Cotter TP, Bredin CP, Buick JB, Lowry RC, MacMahon JJ, Finlay G, Concannon D, McDonnell TJ, Reid PT, Alderdice J, Carson J, Sinnamon DG, Murphy S, Scott T, Keane CT, Walsh JB, Coakley D, McKeown D, Kelly P, Clancy L, Kiely JL, Cryan B, Bredin CP, Killeen P, Farrell S, Kelly P, Clancy L, Kiely JL, O’Riordan DM, Sheehan S, Curtain J, Hogan J, Bredin CP, Malone A, Ahmed S, Watson JBG, Murphy M, Fennell W, Ahmed S, Watson JBG, Aherne T, Keohane C, O’Neill M, Gleeson CM, McGuigan J, Ritchie AJ, Russell SEH, Molloy E, Keane M, Coakley R, Costello R, Condron C, Watson RGW, O’Neill S, Kelly C, Redmond H, Watson W, Burke P, Bouchier-Hayes D, Donnelly SC, Haslett C, Dransfield I, Robertson CE, Carter DC, Ross JA, Grant IS, Tedder TF, Doyle S, Sreenan S, Pathmakanthan S, Burke CM, Heaney LG, Cross LJM, Stanford CF, Ennis M, Sreenan S, Pathmakanthan S, Power C, Goggin A, Poulter LW, Burke CM, Murphy S, Scott T, Keane CT, Walsh JB, Coakley D, O’Riordan DM, Gergely L, Deng N, Rose RM, Hennessy T, Hickey L, Thornton L, Collum C, Durity M, Power J, Johnson H, Lee B, Doherty E, Kelly E, McDonnell T, McKeown D, Kelly P, Clancy L, Wilkinson P, Varghese G, Anikin V, Gibbons J, McManus K, McGuigan J, Reid PT, Gower NH, Rudd RM. Irish thoracic society. Ir J Med Sci 1994. [DOI: 10.1007/bf02967229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
29
|
Cunningham J, O’Neill M, Patrick G, Hickey N, Wang Z, Galwey AK, Fierro JLG. Physicochemical and catalytic characterizations of materials prepared from copper malonate by thermal decomposition or chemical reduction. ACTA ACUST UNITED AC 1994. [DOI: 10.1007/bf02549340] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
30
|
Kent A, Keenan AK, Herity NA, Allen JD, Silke B, Adgey AAJ, O’Halloran KD, Curran AK, Bradford A, Craig JA, Barlas P, Baxter GD, Walsh DM, Allen JM, Logan ID, Wilkinson YA, McKenna PG, Brayden DJ, Dunne J, Baird AW, Kelly JG, O’Connor JJ, Rowan MJ, Anwyl R, Caldwell M, Earley B, Leonard BE, Wedlock PM, Shephard RA, Bracken PJ, Fitzpatrick JM, O’Reilly C, Quinn E, Ryan MP, O’Neill J, Kernan RP, Craven CD, Healy E, Clarke H, Nolan CA, O’Connell C, Deegan PM, Abdelwahab YHA, Barnett CR, Flatt PR, MacSweeney C, Kelly JP, Cawley T, Geraghty J, Osborne H, Docherty JR, Nelson AA, McDowell BC, McCrory M, Deasy PB, Finan MP, Klatt PR, Hornykiewytsch T, Campion DP, Leek BF, Sharma SC, Barry-Kinsella C, Foran K, Thomas G, McKinney MW, O’Connor J, McKelvey-Martin VJ, Thompson CCM, McCarthy PJ, Hannigan BM, Thurnham DI, Chopra M, Leake D, Sheehy PJA, Delanty N, Murphy N, Lawson JA, FitzGerald GA, Fitzgerald DJ, Smyth EM, McCole D, O’Neill M, Canney M, Turley E, Strain JJ, Gallagher GA, Shields TD, O’Kane S, Eason SJ, Gilmore WS, King CM, Hejmadi M, McKeown SR, McAleer JJA, Patterson LH, Gray PSC, Lappin TRJ, Bridges JM, Richardson SAM, Murphy PG, Davidson N, Hooper ACB. Royal Academy of Medicine in Ireland Section of Biomedical Sciences Proceedings of Summer Meeting held 22nd & 23rd June, 1993. Ir J Med Sci 1994. [DOI: 10.1007/bf02965965] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
31
|
MacDermott M, Doolan C, Keenan AK, Twomey C, Doyle M, Kirby F, McDonald N, McShane AJ, Deasy PB, Boles MG, Donnellan MF, Hilton AK, Wall M, Horan R, Houghton JA, Southey A, O’Connor CM, Fitzgerald MX, Scott TG, Fitzgerald MF, Hegarty V, Keane CT, Coakley D, Moran AP, Walsh EJ, Hickey K, Monkhouse S, Folan-Curran J, Caulfield B, Garrett M, Lowe AS, Baxter GD, Walsh DM, Allen JM, Lawlor M, Farrelly C, O’Boyle KM, O’Connell A, Earley B, Leonard BE, Han B, Kelly JP, O’Donnell JM, O’Neill M, Song C, Sherphard RA, Leslie JC, Toal L, Wedlock P, Yeruva N, O’Donovan DJ, Craig JA, Fegan JA, Kent A, Atkinson PRT, Peake J, Thornbury KD, Campion DP, Leek BF, Bird J, Carroll C. Royal academy of medicine in Ireland section of biomedical sciences. Ir J Med Sci 1993. [DOI: 10.1007/bf02942170] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
32
|
McGibney CA, Byrne PJ, Lawlor P, Denham B, Hennessy TPJ, Greally P, Hampton FJ, MacFadyen UM, Simpson H, Gururangan S, McMahon C, Guiney EJ, Fitzgerald RJ, O’Donnell B, Breathnach F, Thomas G, Lambert I, Gill D, Ledwith MV, Conlon P, Cronin C, O’Halpin D, Donoghue V, Webb DW, Osborne JP, Naughten E, Darling G, Saul I, Prakash N, McDonald M, Cosgrove J, Costigan C, Naughten ER, King M, Rowland P, Bressan J, Lillis DF, Loftus BG, Fitzgerald J, Jackson J, Fleming P, Deb L, Temperley IJ, Daly NJ, McShane D, Jackson JF, O’Nuallain EM, Reen DJ, Monaghan H, Dorman A, Ball R, Curran B, Leader M, O’Meara A, Flood T, Sweed Y, Puri P, Twomey M, Duncan J, Kiernan M, Kearney PJ, Abushaban L, Denham B, Duff D, Donnelly MJ, Maguire AJ, Dennis AR, Donnelly M, Aziz MA, Gormally SM, Matthews TG, Fitzsimons R, Ahmed Z, Hensey O, Deshpande D, George A, Rao JS, Gaffney E, Gorman W, Kierce B, Quinn F, Drumm B, Naughton A, McMenamin JB, Stack J, Coveney E, Ninan G, Praedeep Dumar VK, Watson B, O’Neill M. Irish paediatric association. Ir J Med Sci 1992. [DOI: 10.1007/bf02942160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
33
|
Bill KM, Gallagher M, Dempsey M, Pratt IS, O’Connor CM, FitzGerald MX, Murray AM, Waddington JL, McKeating K, Bali IM, Dundee JW, Laird CRD, Gallagher M, Larkin S, Martin F, Schuster W, Dwyer R, Flynn RJ, McMurray T, Moore J, O’Neill M, Andrews JF, Al-Arabi A, Houlden M, Paterson A, Kirkpatrick CT, Crotty TP, McCarron JG, Allen JM, McHale NG, Thornbury KD, McGeown JG, McMurray TJ, Wright J, Phillips SA, Peyton M, O’Toole DP, Keeling F, Bouchier-Hayes D, Cunningham AJ, Jande MB, Sharma SC, Anwyl R, Mulkeen D, Rowan M, O’Connor JJ, Rowan MJ, Anwyl R, Jamison JP, Mercer CG, Victory R, O’Sullivan K, Furness G, McCollum JC, Fee JPH, Collier PS, Boyhan C, Claffey LP, Blunnie WP, Dunphy JA, O’Connell DP, Cooney D, Keenan AK, Treacy M, Martin F, Daly L, Bonnar J, Blurnie WP, McShane AJ, Synnott A, Gilmore JE, Allen JA, Hayes JR, Stevens AB, McKane WR, Bell PM, Bell P, King DJ, Ennis S, O’Regan RG, Kennedy M, Bannigan J, Cottell D, Ennis S, O’Neill B, Fitzpatrick KTJ, Ghaly RG, McGrath LT, Elliott RJ, Biggart DJ, Regan MB, Milligan KR, Howe JP, McKay AC. Royal Academy of Medicine in Ireland Section of Biological Sciences Proceedings of Summer Meeting held on Tuesday and Wednesday, 22nd and 23rd June, 1987. Ir J Med Sci 1988. [DOI: 10.1007/bf02953680] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|